Robertson Andrew G N, Patel Ravi N, Couper Graeme W, de Beaux Andrew C, Paterson-Brown Simon, Lamb Peter J
Department of Upper GI Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK.
ANZ J Surg. 2017 Apr;87(4):300-304. doi: 10.1111/ans.13358. Epub 2015 Oct 19.
Limited evidence exists to which operation gives best long-term outcomes for gastro-oesophageal reflux disease. This study aimed to assess long-term symptomatic outcome and satisfaction following laparoscopic anterior (LA) or Nissen fundoplication in a specialist upper gastrointestinal unit.
Patients who underwent primary LA or Nissen (LN) fundoplication between May 1994 and June 2010 were identified from a prospectively collected database. DeMeester, modified DeMeester, 'Gastrointestinal Symptom Rating Scale' scores and patient satisfaction were assessed by questionnaire.
A total of 387 patients underwent surgery and 246 patients (65%) completed questionnaires, with 181 LA patients and 65 LN patients. Median follow-up was 83 months for LA and 179 months for LN (P < 0.001). A total of 218/245 (89%) reported major improvement in symptoms and 27 (11%) reported poor outcomes. There was no differences between LA and LN for symptom scores at short (<5 years) or long-term follow-up (>5 years). Women reported significantly higher DeMeester scores and lower satisfaction (P = 0.012). One hundred and eighteen (48%) patients were taking proton pump inhibitors (PPI) at follow-up despite high satisfaction rates.
LA and LN have similar long-term results with patients reporting high satisfaction levels. Women reported more symptoms and less satisfaction than men. Despite high satisfaction rates a high percentage of patients take PPIs.
关于哪种手术对胃食管反流病能带来最佳长期疗效的证据有限。本研究旨在评估在一个专业的上消化道科室中,腹腔镜前入路(LA)或nissen胃底折叠术术后的长期症状转归及满意度。
从一个前瞻性收集的数据库中识别出1994年5月至2010年6月期间接受初次LA或nissen(LN)胃底折叠术的患者。通过问卷调查评估DeMeester评分、改良DeMeester评分、“胃肠道症状评分量表”评分及患者满意度。
共有387例患者接受了手术,246例患者(65%)完成了问卷调查,其中LA组181例患者,LN组65例患者。LA组的中位随访时间为83个月,LN组为179个月(P<0.001)。共有218/245(89%)的患者报告症状有显著改善,27例(11%)报告疗效不佳。在短期(<5年)或长期随访(>5年)时,LA组和LN组的症状评分无差异。女性报告的DeMeester评分显著更高,满意度更低(P=0.012)。尽管满意度较高,但118例(48%)患者在随访时仍在服用质子泵抑制剂(PPI)。
LA和LN的长期结果相似,患者报告的满意度较高。女性比男性报告的症状更多,满意度更低。尽管满意度较高,但仍有很高比例的患者服用PPI。